GNS Healthcare Inc (GNS Healthcare) is a provider of causal AI (artificial intelligence) and simulation technology solutions to discover and develop medicines for oncology, immunology and neurodegenerative indications.

The company utilises REFS (reverse engineering, forward simulation), a causal machine learning and simulation platform to unfold the drivers of disease progression and individual patient response to drugs. Its Gemini in silico patient model enables researchers and data scientists to simulate clinical trials, disease progression and drug response.

GNS Healthcare serves pharmaceutical and biotechnology companies. The company works in partnership with pharmaceutical companies, research centres, medical societies, and patient advocacy groups.

GNS Healthcare is headquartered in Somerville, Massachusetts, US.